Previous Close | 40.49 |
Open | 40.00 |
Bid | 0.00 x 900 |
Ask | 0.00 x 1300 |
Day's Range | 39.45 - 40.72 |
52 Week Range | 23.81 - 63.57 |
Volume | |
Avg. Volume | 943,764 |
Market Cap | 4.754B |
Beta (5Y Monthly) | 1.77 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.46 |
Earnings Date | Oct 31, 2023 - Nov 06, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 61.17 |
Subscribe to Yahoo Finance Plus to view Fair Value for TXG
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court ("UPC") issued a preliminary injunction against NanoString Technologies, Inc. (Nasdaq: NSTG) for infringing European Patent 4 108 782 B1 ("the EP 782 patent," docket No 459746/2023). The preliminary injunction, issued by a panel of four judges with both legal and technical expertise, prevents NanoString from selling or providing services using its CosMx Spatial Mo
An in-depth analysis of 10x Genomics Inc's intrinsic value, financial strength, and growth prospects